PeptideScanner retained ClinicalTrials.gov record NCT00002239 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-11-15, and PeptideScanner's reviewed identity mapping was enfuvirtide.
PeptideScanner retained ClinicalTrials.gov record NCT00002049 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.
PeptideScanner retained ClinicalTrials.gov record NCT00002050 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.
PeptideScanner retained ClinicalTrials.gov record NCT00002051 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.
PeptideScanner retained ClinicalTrials.gov record NCT00002066 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.
PeptideScanner retained ClinicalTrials.gov record NCT00002109 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.
PeptideScanner retained ClinicalTrials.gov record NCT00002228 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.
PeptideScanner retained ClinicalTrials.gov record NCT00002289 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.
PeptideScanner retained ClinicalTrials.gov record NCT00002332 at 2026-11-16T17:32:22.993Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was thymopentin.
PeptideScanner retained ClinicalTrials.gov record NCT00008528 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.
PeptideScanner retained ClinicalTrials.gov record NCT00021554 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.
PeptideScanner retained ClinicalTrials.gov record NCT00086710 at 2026-11-16T01:41:15.051Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was enfuvirtide.
PeptideScanner retained ClinicalTrials.gov record NCT00004311 at 2026-07-30T22:50:58.187Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was leuprolide.
PeptideScanner retained ClinicalTrials.gov record NCT00004344 at 2026-07-30T22:50:58.186Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was leuprolide.
PeptideScanner retained ClinicalTrials.gov record NCT00004771 at 2026-07-30T22:50:58.183Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was leuprolide.
PeptideScanner retained ClinicalTrials.gov record NCT00004327 at 2026-07-30T22:50:58.187Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was octreotide.